TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Jim Cramer Explains How Pfizer's Hospira Acquisition Helps Pharmaceutical Giant

Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Dana Holding (DAN) Stock Higher Today Ahead of Joining S&P MidCap 400

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Cubist Pharmaceuticals (CBST) Hits New Lifetime High

3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's New Lifetime High Stock

Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals
MERGERS AND ACQUISITIONS

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Cempra Oral Antibiotic Effective Against Hard-to-Treat Pneumonia

Stock Market Today - China's Factory Activity Contracted in May as Japan's Expanded
INVESTING

Jim Cramer on the Markets: Some Stocks You Just Can't Ignore

3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Cubist Pharmaceuticals (CBST): Today's Pre-Market Leader Stock

Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

Cubist Pharmaceuticals (CBST) Showing Signs Of Being A Momo Momentum Stock

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know

Health Care Stocks: A Year in Review and Predictions for 2015
OPINION

Health Care Stocks: A Year in Review and Predictions for 2015

Mobileye Rises After Morgan Stanley, Deutsche Bank Hike Price Targets
INVESTING

Merck May Have Paid $2B-$3B Too Much For Cubist, Analyst Says

Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

Cubist Pharmaceutical (CBST) Stock Declines Today Following Patent Rejection

Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist
INVESTING

Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Cubist Pharmaceuticals (CBST) Is Today's Perilous Reversal Stock

Jim Cramer's Top Stock Picks: AAL SAVE EW MNK KR
OPINION

Jim Cramer's Top Stock Picks: DIS SBUX NKE ENB MRK CRZO

Jim Cramer's 'Mad Money' Recap: Ignore the Naysayers
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Are Dragged Lower as Oil Prices Plunge to 5-Year Low

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Recover From Session Lows Though Oil Prices Continue to Hurt

ConocoPhillips (COP) Stock Gains Today as WTI Crude Rallies in Trading
MARKETS

Why Jim Cramer Likes Merck's Acquisition of Cubist Pharmaceuticals (CBST)

Merck (MRK) Stock Closed Higher After Winning Gilead Patents Dispute
OPINION

Merck Seeks Growth Injection, Picks Off Antibiotic Maker Cubist

Insurance M&A Seen Heating Up, Led By AIG, Ace and Markel
MERGERS AND ACQUISITIONS

Merck to Buy Cubist Pharmaceuticals in $9.5 Billion Deal

February 27 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Near Flatline as Rally in Pharmaceuticals Overshadows Energy Selloff

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stock Futures Slide as Crude Oil Tumbles Below $65 a Barrel

Will Reports of More Potential Pfizer Acquisitions Affect AbbVie (ABBV) Stock Today?
MARKETS

Cubist Pharmaceuticals (CBST) Stock Skyrockets Today on $8.4 Billion Merck Deal